Eduardo Rocha

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Faculdade de Medicina

Departamento:

Departamento de Clínica Médica/FM

ORCID:

não disponível no Lattes


Formação:

  • Universidade Federal do Rio de Janeiro

    Gestão em Saúde | Especialização | 2012 - 2012

  • Universidade Federal do Rio de Janeiro

    | Pós-Doutorado | 2003 - Agora

  • Universitat Autònoma de Barcelona - UAB

    Transplant Procurement Manager | Especialização | 1998 - 1998

  • Universidade Federal de São Paulo

    Medicina (Nefrologia) | Doutorado | 1997 - 2001

  • Universidade do Estado do Rio de Janeiro

    Medicina (Nefrologia) | Mestrado | 1992 - 1997

  • Hôpital Necker Enfants Malades

    Residência Médica Em Nefrologia e Transplantes | Especialização | 1990 - 1991

  • Universidade do Estado do Rio de Janeiro

    Residência Médica Em Nefrologia | Especialização | 1987 - 1989

  • Universidade Federal do Rio de Janeiro

    Medicina | Graduação | 1981 - 1986
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:

(38.24% artigos com DOI)

Titulo DOI Ano
Predialysis hypernatremia is a prognostic marker in acute kidney injury in need of renal replacement therapy 10.1016/j.jcrc.2015.05.023 2015
Developing learning capabilities through a quality management program 10.1080/02642069.2015.1042972 2015
Family Informed Consent to Organ Donation-Who Performs Better: Organ Procurement Organizations, In-Hospital Coordinators, or Intensive Care Unit Professionals? 10.1016/j.transproceed.2014.05.036 2014
The C-terminal domain of A1/Bfl-1 regulates its anti-inflammatory function in human endothelial cells 10.1016/j.bbamcr.2013.03.001 2013
The evaluation of sequential platelet counts has prognostic value for acute kidney injury patients requiring dialysis in the intensive care setting 10.6061/clinics/2013(06)13 2013
Acute Kidney Injury Network Criteria as a Predictor of Hospital Mortality in Cirrhotic Patients With Ascites 10.1097/MCG.0b013e31822e8e12 2012
Outcomes of cancer and non-cancer patients with acute kidney injury and need of renal replacement therapy admitted to general intensive care units 10.1093/ndt/gfq441 2011
A murine model of xenotransplantation of human glioblastoma with imunosupression by orogastric cyclosporin 10.1590/S0004-282X2011000100021 2011
SAPS 3 scores at the start of renal replacement therapy predict mortality in critically ill patients with acute kidney injury: SAPS 3 and MPM0-III in ICU patients with AKI 10.1038/ki.2009.385 2010
Outcomes of critically ill patients with acute kidney injury and end-stage renal disease requiring renal replacement therapy: a case-control study 10.1093/ndt/gfn750 2009
Effects of early changes in organ dysfunctions on the outcomes of critically ill patients in need of renal replacement therapy 10.1590/S1807-59322008000300010 2008
Performance of six prognostic scores in critically ill patients receiving renal replacement therapy 10.1590/S0103-507X2008000200001 2008
RIFLE classification in patients with acute kidney injury in need of renal replacement therapy 10.1007/s00134-007-0535-0 2007
Reply to the comment by Bellomo et al. 2007
Solute removal by hollow-fiber dialyzers. 2007
Therapeutic and prophylactic thalidomide in TNBS-induced colitis: synergistic effects on TNF-alpha, IL-12 and VEGF production. 2007
RIFLE classification does not predict outcome in dialytic acute kidney dysfunction 2006
Comparing Strategies to Prevent Extracorporeal Circuit Coagulation in Continuous Renal Replacement Therapies: Role of Citrate Anticoagulation 2006
Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells. 2005
Effects of customized bicarbonate buffered solutions for continuous renal replacement therapies on polymorphonuclear leukocytes function and viability 2004
Regional citrate anticoagulation: impact on membrane survival 2003
Adjusting the intensity of renal support to the patients'need: the R.I.O.S. experience 2002
The BH4 domain of A1, a Bcl-2 family member, is necessary and sufficient for its anti-inflammatory functionin endothelial cells. 2001
Customized bicarbonate buffered dialysate and replacement solutions for Continuous Renal Replacement Therapies: effect of crystallization on the measured levels of electrolytes and buffer. 2001
Prevenção de apoptose e ativação de células endoteliais em cultura através da transferência do gene A1, da família Bcl-2 2001
Biocompatibility of customized replacement solutions (CRS) for continuous replacement therapies (CRRT): effect of calcium/bicarbonate crystalization on the concentration of differentsalts. 2000
Biocompatibilidade de soluções com bicarbonato para terapias contínuasde substituição da função renal 2000
Recuperação da função renal em pacientes com insuficiência renal aguda tratados com hemodiálise intermitente vs. contínua e soluções de bicarbonato em terapia intensiva 2000
Successful metabolic control with the use of customized bicatbonate solutions in CRRT. 1999
On-line produced bicarbonate-buffered dialysate for CRRT is pro-inflammatory 1999
Single-bag bicarbonate solutions in CRRT - is that safe? 1999
Early gestational hemolytic uremic syndrome: case report and review of literature. 1997
Cytomegalovirus infections after kidney transplantation: identical risk wheter donor or recipient is thevirus carrier. 1991
Infecção por citomegalovírus (CMV) após profilaxia de rejeição com anticorpo monoclonal OKT3 e ciclosporina A 1990
Eventos:
Nenhum evento cadastrado
Publicações:
Minha Rede: